CH616944A5 - - Google Patents
Download PDFInfo
- Publication number
- CH616944A5 CH616944A5 CH1047575A CH1047575A CH616944A5 CH 616944 A5 CH616944 A5 CH 616944A5 CH 1047575 A CH1047575 A CH 1047575A CH 1047575 A CH1047575 A CH 1047575A CH 616944 A5 CH616944 A5 CH 616944A5
- Authority
- CH
- Switzerland
- Prior art keywords
- hydroxy
- alkyl
- compound
- methyl
- reaction
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0081—Substituted in position 17 alfa and 17 beta
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
- C07J53/002—Carbocyclic rings fused
- C07J53/004—3 membered carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/001—Oxiranes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NLAANVRAGE7411607,A NL188647C (nl) | 1952-03-29 | 1974-09-02 | Werkwijze voor het bereiden van 11beta-hydroxy-18-alkylestraanverbindingen. |
Publications (1)
Publication Number | Publication Date |
---|---|
CH616944A5 true CH616944A5 (sv) | 1980-04-30 |
Family
ID=19822010
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH1047575A CH616944A5 (sv) | 1974-09-02 | 1975-08-12 |
Country Status (12)
Country | Link |
---|---|
US (1) | US4031074A (sv) |
JP (1) | JPS5148647A (sv) |
CA (1) | CA1069117A (sv) |
CH (1) | CH616944A5 (sv) |
DD (1) | DD124880A5 (sv) |
DE (1) | DE2538862C2 (sv) |
DK (1) | DK138499B (sv) |
FR (1) | FR2283150A1 (sv) |
GB (1) | GB1519826A (sv) |
HU (1) | HU173555B (sv) |
SE (1) | SE415021B (sv) |
SU (1) | SU826957A3 (sv) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU572589B2 (en) | 1983-12-14 | 1988-05-12 | Upjohn Company, The | 11(alpha)-difluoromethyl and (e)-and (z)-11-fluoromethylene steroids |
MXPA05001857A (es) * | 2002-08-16 | 2005-06-03 | Upjohn Co | Intermedios esteroideos de 5-androsten-38-ol y procedimientos para su preparacion. |
US20070066579A1 (en) * | 2002-08-16 | 2007-03-22 | White Michael J | 5-androsten-3beta-ol steroid intermediates and processs for their preparation |
HUE046656T2 (hu) | 2012-03-15 | 2020-03-30 | Merck Sharp & Dohme | Kombinált szintézisútvonal etonogestrel és desogestrel számára |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3780026A (en) * | 1969-01-13 | 1973-12-18 | Shionogi & Co | Biochemical aldosterone synthesis |
-
1975
- 1975-07-18 US US05/597,271 patent/US4031074A/en not_active Expired - Lifetime
- 1975-07-29 GB GB31661/75A patent/GB1519826A/en not_active Expired
- 1975-08-07 CA CA233,054A patent/CA1069117A/en not_active Expired
- 1975-08-12 CH CH1047575A patent/CH616944A5/de unknown
- 1975-08-22 DK DK379775AA patent/DK138499B/da not_active IP Right Cessation
- 1975-08-27 JP JP50104464A patent/JPS5148647A/ja active Granted
- 1975-08-29 HU HU75AO422A patent/HU173555B/hu not_active IP Right Cessation
- 1975-08-29 DD DD188093A patent/DD124880A5/xx unknown
- 1975-09-01 SE SE7509674A patent/SE415021B/sv not_active IP Right Cessation
- 1975-09-01 DE DE2538862A patent/DE2538862C2/de not_active Expired
- 1975-09-01 SU SU752170509A patent/SU826957A3/ru active
- 1975-09-02 FR FR7526925A patent/FR2283150A1/fr active Granted
Also Published As
Publication number | Publication date |
---|---|
DK379775A (sv) | 1976-03-03 |
DD124880A5 (sv) | 1977-03-16 |
DE2538862C2 (de) | 1984-08-02 |
DE2538862A1 (de) | 1976-03-11 |
FR2283150A1 (fr) | 1976-03-26 |
JPS6211000B2 (sv) | 1987-03-10 |
JPS5148647A (en) | 1976-04-26 |
CA1069117A (en) | 1980-01-01 |
HU173555B (hu) | 1979-06-28 |
DK138499C (sv) | 1979-02-26 |
SE7509674L (sv) | 1976-03-03 |
SE415021B (sv) | 1980-09-01 |
FR2283150B1 (sv) | 1979-09-14 |
US4031074A (en) | 1977-06-21 |
DK138499B (da) | 1978-09-18 |
GB1519826A (en) | 1978-08-02 |
SU826957A3 (ru) | 1981-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE1468035A1 (de) | Verfahren zur Herstellung von 19-Alkylsteroiden | |
DE2538862C2 (de) | Verfahren zur Herstellung von 11β-Hydroxy-18-alkyl-steroiden der Östranreihe | |
CH651053A5 (de) | Steroid-zwischenprodukte. | |
DE1543274A1 (de) | Verfahren zur Herstellung von 4-Keto-4,6-bisdehydro-6-halogen-9beta,10alpha-sterioden | |
DE2531145C2 (de) | Verfahren zur Herstellung von 11beta-Hydroxy-18-alkyl-steroiden der Östranreihe | |
DE1518666A1 (de) | Verfahren zur Herstellung von 13,14-Seco-steroiden | |
DE2037402A1 (de) | Verfahren zur Herstellung von 7 alpha Methylsteroiddenvaten | |
DE1443124C (de) | Verfahren zur Herstellung von Gonan Derivaten | |
DE1468988B1 (de) | 17alpha-Chloraethinyl-13beta-aethyl-4- oder -5(10)-gonen-3-ketone | |
DE1468988C (de) | nalpha-Chloräthinyl-lSbeta-äthyl-4-oder-5( 10)- gonen-3 -ketone.' | |
AT205679B (de) | Verfahren zur Herstellung 3, 11, 17-substituierter Steroide | |
DE1568688C3 (de) | Verfahren zur Herstellung von 3-Oxo-4,6-dehydro-19-nor-steroiden, sowie 17 beta-Hydroxy-8 alpha, 10 alpha-östra-4,6-dien-3-on | |
DE1238021B (de) | Verfahren zur Herstellung von Verbindungen der Pregnanreihe | |
AT211966B (de) | Verfahren zur Herstellung 3,11,17-substituierter Steroide | |
DE1618855B2 (de) | Gonanen-3,17-diole und verfahren zu ihrer herstellung | |
AT271759B (de) | Verfahren zur Herstellung von neuen 1,2β-Methylensteroiden | |
DE1668665C (de) | Verfahren zur Herstellung von 13-Alky 1-gona-1,3,5( 10)-trienen. Ausscheidung aus: 1443123 | |
DE1468227C (de) | Verfahren zur Herstellung von Delta hoch 4 - bzw. Delta hoch 5 -ungesättigten Steroiden der Androstan-, Pregnan- und Sapogeninreihe mit einer freien oder veresterten Hydroxygruppe in 19-Stellung | |
DE1443124B (de) | Verfahren zur Herstellung von Gonan-Derivaten | |
DE1807585A1 (de) | 14,15ss-Epoxycardenolide | |
DE2057171A1 (de) | Verfahren zur Herstellung von neuen alpha-Hydroxy-11ss-nitro-oxysteroiden mit einem aromatischen A-Ring | |
DE1126384B (de) | Verfahren zur Herstellung von 17 ª‡-niedrig-Alkyl- und 17ª‡-niedrig-Alkinylderivaten des 19-Nor-í¸-androsten-3ª‰, 17ª‰-diols | |
DE1493168A1 (de) | 5 alpha-Androstanolon-derivate und Verfahren zu ihrer Herstellung | |
DE1493168B (de) | Verfahren zur Herstellung von 5alpha-Androstanolon-derivaten | |
CH396900A (de) | Verfahren zur Herstellung neuer Derivate der östrogenen Hormone |